Rapid Rx Quiz: COVID Treatments

Mary L. Windle, PharmD


March 01, 2022

Remdesivir is indicated for treatment of COVID-19 in patients aged ≥ 12 years who weigh ≥ 40 kg (88.2 lb), have positive results on direct viral testing for SARS-CoV-2, and require hospitalization, or in those who are not hospitalized, have mild to moderate COVID-19, and are at high risk for progression to severe COVID-19 (including hospitalization or death).

Remdesivir, an antiviral agent, was the first treatment to gain full FDA approval for COVID-19. In addition to its approved indication, it has EUA for young children who weigh at least 3.5 kg as both inpatient and outpatient treatment regimens. It is administered by intravenous infusion.

Learn more about remdesivir indications.

This Rapid Review Quiz was excerpted and adapted from the Medscape articles: remdesivir, molnupiravir, nirmatrelvir/ritonavir, and COVID-19 Treatment and Management.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.